GT
ASTX

Glenmede Trust’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Glenmede Trust’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$8K – 2415
2013
Q3 		$8K Sell
1,000
-81,331
-99% -$515K ﹤0.01% 1975
2013
Q2 		$338K Buy
+82,331
New +$443K ﹤0.01% 907

Glenmede Trust's ASTX Position: Q4 2013 in Review

Glenmede Trust sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,000 shares — an estimated $8K sold.

Glenmede Trust first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $338K in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Glenmede Trust reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Glenmede Trust sold 1,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $8K.
  • Glenmede Trust first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Glenmede Trust's ASTEX PHARMACEUTICALS, INC COM position peaked at $338K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.